All results
76 results
-
A Phase 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Omadacycline in Adult Subjects with Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by
This study is investigating the efficacy, safety, and tolerability, of an antibiotic medication called omadacycline in adult subjects with Nontuberculous…
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Tolerability, Safety, and Efficacy of PRAX-944 in the Treatment of Adults with Essential Tremor
This multi-center, randomized, double-blind, placebo-controlled, dose-range-finding clinical trial will assess the efficacy, safety, and tolerability of…
- Ages
- N/A
- Sexes
- All
-
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with Treatment-refractory Mycobacterium avium Complex Lung
The purpose of this study is to learn about the effects of epetraborole in patients with refractory MAC, including to assess the efficacy for treating…
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
A Phase 3, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial To Evaluate The Efficacy And Safety Of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)
This is a Phase 3, double-blind, randomized, placebo-controlled trial of Reldesemtiv in patients aged 18 to 80 with ALS. A drug named "Reldesemtiv" is being…
- Ages
- N/A
- Sexes
- All
-
A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety
This is a study to learn the effectiveness of an investigational drug to prevent pregnancy, the safety and tolerability of wearing the patch. Healthy female…
- Ages
- 18 Years - N/A
- Sexes
- Female
-
A Phase 3, multi-centre long-term extension study to assess the safety and efficacy of GSK3196165 in the treatment of rheumatoid arthritis.
This is a long-term extension study of up to about 4 years for people with RA who may benefit from extended treatment with otilimab, after completing the…
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Phase 3, multi-centre long-term extension study to assess the safety and efficacy of GSK3196165 in the treatment of rheumatoid arthritis.
This research study is being done to learn more about how well an investigational study drug, called otilimab, works and how safe it is when taken for a longer…
- Ages
- N/A
- Sexes
- All
-
A Phase 3, multi-centre long-term extension study to assess the safety and efficacy of GSK3196165 in the treatment of rheumatoid arthritis.
This is a Phase 3 study. This means that the study drug has already been tested in healthy volunteers and people with RA (such as the contRAst-1, contRAst-2,…
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of Tozorakimab in Participants with Symptomatic Chronic Obstructive Pulmonary Disease
The purpose of this Phase III study is to evaluate the efficacy and safety of tozorakimab, a human immunoglobulin G1 monoclonal antibody (mAb). Tozorakimab is…
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
A Phase IIa Randomized, Parallel Group, Double-Blind, Placebo-Controlled, Repeat Dose, Multi-Site Study Investigating the Safety, Tolerability, and Efficacy of Personalized Phage Treatment and Standard of Care Antimicrobials for Patients with Diabetic
This is a phase IIa trial designed to evaluate personalized S. aureus bacteriophage therapy in patients with S. aureus-positive diabetic foot osteomyelitis…
- Ages
- 18 Years - 89 Years
- Sexes
- All